The Japanese Ministry of Health, Labour, and Welfare (MHLW) has granted approval to Sarepta Therapeutics’ gene therapy Elevidys (delandistrogene moxeparvovec) for treating Duchenne muscular ...

The company reported lower-than-expected revenue for its gene therapy product, Elevidys, in the first quarter of 2025, which amounted to $375 million, falling short of the $444 million forecasted ...

Matt Bellina Regained Function After Receiving NurOwn via the Right to Try Law He Fought to Pass and Now He is Fighting for All Americans with ALS to Get the Same Chance He Did BREMERTON, WA / ACCESS ...

As Japan moves through its ground-breaking biomedical research and regulatory environment, The Japan Cell and Gene Therapy Market is poised for significant growth: between 2023 and 2032, the market is ...

Cellares, in collaboration with Mitsui Fudosan, will establish Japan’s first next-gen commercial production site for CAR-T cell therapies. The facility is under construction in Kashiwa City.

Tokyo - An asylum-seeker collapsed and died after staff at a Japanese immigration centre failed to call for help, allegedly because the doctor was having lunch, a pressure group said on Thursday.